Pfizer PFE
NYSE PFE
$27.54 -0.52 (-1.85%)
At close: Nov 19, 2026 · 4:01 PM EST

Pfizer (PFE) Capital Expenditures (2009 - 2026)

Updated

Pfizer (PFE) recorded Capital Expenditures of $573 million in Q3 2026, down 4.8% from $602 million a year earlier but up 7.5% from the prior quarter.

Analysis

Pfizer (PFE) Capital Expenditures (2009 - 2026) Analysis & Trends

On a TTM basis, Pfizer's Capital Expenditures came in at $2.39 billion as of Sep 27, 2026, down 11.6% year-over-year; for FY2025, it came in at $2.63 billion, down 9.6% from FY2024.

  • Annual Capital Expenditures has a five-year compound annual growth rate of 3.4% (FY2020 to FY2025).
  • Across earlier years, Capital Expenditures came in at $2.91 billion in FY2024 (-25.5%), $3.91 billion in FY2023 (+20.7%), $3.24 billion in FY2022 (+19.4%) and $2.71 billion in FY2021 (+21.8%).
  • Quarterly Capital Expenditures has ranged from $436 million in Q1 2026 to $1.14 billion in Q1 2023 over the past five years.
  • On a year-over-year basis, Capital Expenditures has declined for 11 consecutive quarters, with an average decline of 11.5% over the last eight quarters.
  • Peak year-over-year performance for Capital Expenditures in the last five years was growth of 77.1% in Q1 2023, against a decline of 38.2% in Q1 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at $533 million (Q2 2026), $436 million (Q1 2026) and $845 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00 -39,045.00
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn 3.18 Bn
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn 1.36 Bn
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn 301.00 Mn
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn 1.04 Bn
6 Novartis Ag 291.91 Bn 265.14 Bn - -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn 587.00 Mn
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn 237.00 Mn
9 Gsk 193.54 Bn 176.38 Bn - -
10 Pfizer 156.44 Bn 103.79 Bn 12.56 Bn 573.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 27, 2026 573.00 Mn
Jun 28, 2026 533.00 Mn
Mar 29, 2026 436.00 Mn
Dec 31, 2025 845.00 Mn
Sep 28, 2025 602.00 Mn
Jun 29, 2025 618.00 Mn
Mar 30, 2025 564.00 Mn
Dec 31, 2024 917.00 Mn
Sep 29, 2024 651.00 Mn
Jun 30, 2024 637.00 Mn
Mar 31, 2024 704.00 Mn
Dec 31, 2023 1.04 Bn
Oct 1, 2023 810.00 Mn
Jul 2, 2023 914.00 Mn
Apr 2, 2023 1.14 Bn
Dec 31, 2022 1.00 Bn
Oct 2, 2022 841.00 Mn
Jul 3, 2022 751.00 Mn
Apr 3, 2022 643.00 Mn
Dec 31, 2021 1.00 Bn
API Access

Pfizer Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=PFE&period=max&api_key=YOUR_API_KEY